THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM;THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
发明人:
HERGENROTHER, PAUL J.,BOOTHMAN, DAVID A.,BAIR, JOSEPH S.,CAO, LIFEN,GAO, JIMMING,HUANG, XIUMEI,LUO, XIUQUAN,MA, XINPENG,MOORE, ZACHARY R.,PARKINSON, ELIZABETH I.
申请号：
CA2909091
公开号：
CA2909091A1
申请日:
2014.04.08
申请国别(地区):
CA
年份:
2014
代理人:
摘要：
The therapies described herein can be selectively lethal toward a variety of different cancer cell types and cancer conditions in a subject. The combination therapies described herein can be useful for the management, treatment, control, or adjunct treatment of diseases, where the selective lethality is beneficial in chemotherapeutic therapy, particularly where the disease is accompanied by elevated levels of NQO1.
